跳至主要内容
临床试验/NCT03794115
NCT03794115Unknown不适用

Differential Expression of Immune Repertoire of T/B Lymphocytes in Ovarian High Grade Serous Carcinoma

Lei Li1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2019年1月3日最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
40
试验地点
1
主要终点
Expression rates of T lymphocyte receptors

研究概览

简要总结

In this preliminary study, peripheral blood and carcinoma tissue with pericarcinomatous tissue are taken from the patients with ovarian high grade serous carcinoma at several points: before any treatment, after the debulking surgery, and after all the proposed chemotherapy. The differential expression of the T/B lymphocyte receptors in these samples will be analyzed with the platinum-based treatment and survival outcomes of the patients. The primary objective is the expression rates of T/B lymphocyte receptors in different stages of checking points.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Confirmed of primary ovarian high grade serous carcinoma
  • Aged 18 years or older
  • No immunosuppressive disease
  • Signed an approved informed consents

排除标准

  • Not meeting all of the inclusion criteria

结局指标

主要结局

Expression rates of T lymphocyte receptors

时间窗: One year

Expression rates of T lymphocyte receptors in different stages of checking points, including timings before any treatment, after the debulking surgery, and after all the proposed chemotherapy

Expression rates of B lymphocyte receptors

时间窗: One year

Expression rates of T lymphocyte receptors in different stages of checking points, including timings before any treatment, after the debulking surgery, and after all the proposed chemotherapy

次要结局

未报告次要终点

研究者

发起方
Lei Li
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Lei Li

Professor

Peking Union Medical College Hospital

研究点 (1)

Loading locations...

相似试验

Immune Repertoire of Ovarian HGSC | 临床试验